Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

White House acknowledges Lilly chief's role in patent reform victory

This article was originally published in Scrip

Executive Summary

After six years of lawmakers engaged in bartering, quibbling and wrangling, while corporate America and the academic community waited six long decades for change, a US president is enacting an historic overhaul of the nation's patent system on 16 September. But without the keen horse-trading skills of Lilly CEO Dr John Lechleiter and his willingness to give a little, that victory may not have happened this year, a White House official acknowledged.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC014472

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel